Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (Changchun Changsheng Life Sciences)

四价流感病毒裂解疫苗（长春长生生物）

Report date: 2023/05/31 20:00:53

Base Information

Drug NameInfluenza Vaccine (Split Virion), Inactivated, Quadrivalent (Changchun Changsheng Life Sciences)
Drug Alias NameTetravalent influenza vaccine (Changchun Changsheng Life Sciences)
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2018/06/08
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaWithdrawn
Originator CompaniesChangchun Longevity Biological Technology Limited Liability Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChangchun Longevity Biological Technology Limited Liability Company
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeJ07BB02
Related LinksN/A